CFH polymorphism and laser coagulation of drusen

CFH polymorphism and laser coagulation of drusen - CFH & drusen

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33713

Enrollment

Registered

2009-03-19

Start date

2009-05-12

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drusen

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participant of study OZR-2002-15 / MEC 225.001/2003/32.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
Success laser treatment & CFH Y402H polymorphism.	—

Countries

Netherlands

Outcome results